Accelrys Inc.
10188 Telesis Court
Suite 100
San Diego,
CA 92121
United States - Map
Phone: 858-799-5000
Fax: 858-799-5100
Web Site: http://www.accelrys.com
| Accelrys, Inc. engages in the design, development, marketing, and support of software based solutions that facilitate the discovery and development of products and processes in the pharmaceutical, biotechnology, energy, chemical, aerospace and defense, automotive, and consumer packaged goods industries worldwide. The company offers scientific operating platform that enables users to aggregate, integrate, and mine structured and unstructured scientific data, such as chemical structures, biological sequences, and complex digital images, as well as filters, normalizes, and performs statistical analysis on scientific data, and provides interactive visual reports to scientists and scientific managers. It also provides computer aided design modeling and simulation software that enables scientists to perform computations of chemical, biological, and materials properties for simulation, visualization, and analysis of chemical and biological systems, as well as to communicate the results to other scientists. In addition, the company offers cheminformatics software, which is designed to capture, store, manage, and mine chemical information. Further, it delivers a range of solutions from software wrappers that enable customers to run their algorithms on its scientific operating platform, to enterprise-wide life science informatics systems that integrate customers’ internal systems with software from vendors, as well as contract research services; and onsite training, implementation, Web-based training, and data migration services. The company sells products and services through its direct sales force and telesales, as well as through distributors. Accelrys, Inc. was founded in 1993 is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Mark J. Emkjer , 52
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Rick E. Russo , 56
Chief Financial Officer and Sr. VP |
$
382.00K | N/A | Mr. David R. Mersten , 43
Sr. VP, Sec. and Gen. Counsel |
$
352.00K | N/A | Mr. Frank K. Brown Ph.D.,
Chief Science Officer and Sr. VP |
$
342.00K | N/A | Dr. Stephen A. Spearman Ph.D., 58
Exec. VP, Chief Operating Officer of Pharmacopeia Drug Discovery Inc. and Exec. VP of Pharmacopeia Drug Discovery Inc |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
5.18% Nasdaq 
Profile
